Simply convenient.1

The prefilled insulin pen used by millions of people with diabetes worldwide.2,3

NovoMix® 30 FlexPen®
NovoRapid® FlexPen®

Simple to use.1
No loading required.3,4

Each FlexPen® comes prefilled, so no loading required3,4.
With multiple pens in one box, FlexPen® offers a convenient1 option for today’s lifestyle!

Easy to identify

Each pen and packaging is colour-coded, making it easy to identify which insulin you are using.

Designed with FlexPen® users in mind1

When designing FlexPen®, we sought the advice of people with diabetes. They helped us design a pen that was easy to identify and convenient to use.

FlexPen®: produced with the environment in mind6

For people who care about their carbon footprint, FlexPen® is an environmentally sound choice.

A daily environmental impact equivalent to a cup of tea6,7†

†40 units of Active Pharmaceutical Ingredient and one needle per day6,8 vs a 400 mL cup of Darjeeling tea (which has a cradle to grave carbon footprint including cultivation and brewing of 0.15 kg of CO2 equivalents per litre of tea).7

Could FlexPen®
be right for you?

Download and print the information sheet below to learn more about FlexPen®. If you think you could benefit from this device, take the information sheet with you to your next doctor’s appointment to discuss if FlexPen® could be right for you.

Download PDF Download PDF

NovoMix® 30 and NovoRapid® are prescription medicines. NovoMix® 30 contains soluble insulin aspart (rys) and protamine-crystallised insulin aspart (rys) 100 units per mL in the ratio of 30:70. NovoRapid® contains soluble insulin aspart (rys) 100 units per mL. For the treatment of diabetes mellitus. Ask your doctor if NovoMix® 30 or NovoRapid® are right for you. NovoMix® 30 and NovoRapid® have risks and benefits. Further details can be found in the Consumer Medicine Information

Consumer Medicine Information for NovoMix® 30 FlexPen®
Consumer Medicine Information for NovoRapid® FlexPen®
Privacy

Use strictly as directed. If symptoms continue or you have side effects see your doctor. Dosage is determined by a doctor. NovoMix® 30 and NovoRapid® should be administered immediately before a meal, or when necessary after the start of a meal. Resuspend immediately before use. Subcutaneous injection only.

This website is intended for residents of New Zealand only.

Note: This is general information only on the features/benefits of FlexPen®. You should check with your own doctor regarding details for your individual treatment.
Novo Nordisk Pharmaceuticals Ltd., G.S.T. 53 960 898. PO Box 51268 Pakuranga, Auckland, New Zealand. NovoCare® Customer Care Centre (NZ) 0800 733 737 www.novonordisk.co.nz ® Registered® trademark of Novo Nordisk A/S. TAPS(DA) NA 9767. NZ/DV/1217/0124 February 2018. MIX0135. Last updated 5th February 2018.